Status:
COMPLETED
Brief Cognitive Behavioral Therapy to Treat Itch Rumination "Itch CBT" in Eczema
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
The main purpose of this study is to adapt cognitive behavior therapy (CBT) to improve itch in children with eczema.
Detailed Description
Eczema is characterized by chronic itch. Many children develop a chronic focus (rumination) on their itch. Rumination is a maladaptive method of responding to distress, in which the individual thinks ...
Eligibility Criteria
Inclusion
- Moderate to severe atopic dermatitis \[assessed by Patient Oriented Eczema Measure (POEM)score of \>-8 OR NRS itch score of \>= 4\].
- English speaking.
- Currently receiving treatment at Lurie Children's Hospital for atopic dermatitis.
- Parent or guardian available to participate in protocol.
- Have sufficient technology (e.g., cell phone, computer, tablet, etc.) that can be used to access Zoom conference technology for telemedicine visits.
Exclusion
- Inability to comprehend and complete questionnaires.
- History of intellectual disability or psychosis.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04486742
Start Date
September 1 2020
End Date
December 21 2021
Last Update
November 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lurie Children's Hospital
Chicago, Illinois, United States, 60611